From : Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G>
To : Liu; ConsultantRosieO'Neill <AlvinLiuRosie Grieves (ConsultantRosieO'Neill>; Jillian RO'Neill
Subject : RE: Pfizer/BioNTech- Quality Form and Shipping Information
Cc : Maia NikoleishviliMaiaNatia KhmaladzeNatiaAlexander KhvtisiashviliAlexandergkhalil@unicef.org <gkhalil@unicef.org>; domentes@who.int; Hannah Kettler (ConsultantHannahKatherine HudakKatherineBeka DzamashviliBekaetikaradze@yahoo.de <etikaradze@yahoo.de>; sgagua@gov.ge; Giorgi TsotskolauriGiorgiBeka JakeliBekaetikaradze@yahoo.de <etikaradze@yahoo.de>
Received On : 23.03.2021 05:14
Attachments :

Dear Alvin

Thanks for your reply, Hereby I confirm that the Tbilisi Central Warehouse, Kutaisi Regional Warehouse and Batumi Regional Warehouse all will have Ultra low temperature (ULT) freezers to store the vaccine. Thank you for sharing the redistribution considerations, this is very helpful.

With kind regards

 

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

 

Sincerely,

Tamar Gabunia, MD, MPH

First Deputy Minister

 

cid:image001.jpg@01D50033.645805C0

 

 

 

From: Liu, Alvin [mailto:Alvin.Liu@pfizer.com]
Sent: 23 March, 2021 00:05
To: Tamar Gabunia ; Rosie Grieves (Consultant ; O'Neill, Jillian R
Cc: Maia Nikoleishvili ; Natia Khmaladze ; Alexander Khvtisiashvili ; gkhalil@unicef.org; domentes@who.int; Hannah Kettler (Consultant ; Katherine Hudak ; Beka Dzamashvili ; etikaradze@yahoo.de; sgagua@gov.ge; Giorgi Tsotskolauri ; Beka Jakeli ; etikaradze@yahoo.de
Subject: RE: Pfizer/BioNTech- Quality Form and Shipping Information

 

Thank you Dr. Gabunia.  Please let me confirm that the Tbislisi Central Warehouse, Kutaisi Regional Warehouse and Batumi Regional Warehouse all will have Ultra low temperature (ULT) freezers to store the vaccine?  We do not need an official translation of the additional guidance the government has provided, we just would like to reconfirm the cold chain strategy for managing the distribution of the vaccine once it arrives to Tbislisi.  Thanks in advance – I’ve attached a resource that our supply chain team has developed in case you it may be useful for your team.  Appreciate the timely follow-up. 

 

Regards,

Alvin

 

From: Tamar Gabunia <tgabunia@moh.gov.ge>
Sent: Monday, March 22, 2021 3:11 PM
To: Liu, Alvin <Alvin.Liu@pfizer.com>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>; gkhalil@unicef.org; domentes@who.int; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>; etikaradze@yahoo.de; sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; etikaradze@yahoo.de
Subject: [EXTERNAL] RE: Pfizer/BioNTech- Quality Form and Shipping Information

 

Dear Alvin

Many thanks for your e-mail and this update. Great to hear that the vaccines and diluent will be delivered this Wednesday. Attached you can find the National Vaccine Deployment Plan which provides consideration for storage and distribution of the ultra-cold chain vaccines. Beside this, the Governmental order specifies additional requirements for Pfizer vaccine administering clinical sites. We have it available in Georgian language. Please kindly let me know if you would like to have a copy in English.

With kind regards

 

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

 

Sincerely,

Tamar Gabunia, MD, MPH

First Deputy Minister

 

cid:image001.jpg@01D50033.645805C0

 

 

 

From: Liu, Alvin [mailto:Alvin.Liu@pfizer.com]
Sent: 22 March, 2021 21:54
To: Tamar Gabunia <tgabunia@moh.gov.ge>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>; gkhalil@unicef.org; domentes@who.int; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>; etikaradze@yahoo.de; sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; etikaradze@yahoo.de
Subject: RE: Pfizer/BioNTech- Quality Form and Shipping Information

 

Dear Dr. Gabunia,

 

Thank you again for providing all of the documentation.  We are currently planning for delivery of both the vaccine and diluent this week on Wednesday.  I went through all of the forms you sent and realized I did not have a copy of your national vaccine deployment plan outlining the government of Georgia’s considerations of storage and in-country distribution of Covid-19 vaccines requiring ultra cold-chain.  When you get a moment could you please forward it to me?  Please do not hesitate to reach out with any further questions.  Many thanks.


Regards,

Alvin 

 

 

From: Tamar Gabunia <tgabunia@moh.gov.ge>
Sent: Friday, March 5, 2021 11:40 AM
To: Liu, Alvin <Alvin.Liu@pfizer.com>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>; gkhalil@unicef.org; domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>; etikaradze@yahoo.de; sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; etikaradze@yahoo.de
Subject: [EXTERNAL] Pfizer/BioNTech- Quality Form and Shipping Information

 

Dear Alvin

 

Many thanks for addressing our questions related to the importer of record, shipping locations and quality forms. Please find attached completed and singed documents. In addition I am sending NRA letter expressing regulatory readiness on issuing the import permit immediately upon receiving the shipping documents.  Mr. Otar Namicheishvili, is in charge of clearance procedures on behalf of the National Center for Disease Control and Public Health

Contact Information:

Otar Namicheishvili

+995 577 388 000

o.namicheishvili@ncdc.ge

Please kindly let me know if anything else is required.

With kind regards

 

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

 

Sincerely,

Tamar Gabunia, MD, MPH

First Deputy Minister

 

cid:image001.jpg@01D50033.645805C0

 

 

 

From: Liu, Alvin [mailto:Alvin.Liu@pfizer.com]
Sent: 5 March, 2021 07:27
To: Tamar Gabunia <tgabunia@moh.gov.ge>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>; gkhalil@unicef.org; domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>; etikaradze@yahoo.de; sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; etikaradze@yahoo.de
Subject: RE: Pfizer/BioNTech- Indemnification Agreement

 

Dear Dr. Gabunia,

 

Thank you for sending the executed agreements.  Our legal team is finalizing their review and hope to have fully executed documents to you shortly.  In advance of our call tomorrow, I am attaching two documents for your review that we will briefly cover  confirming details  of:

 

1.)    The importer of record and shipping locations for the vaccine and diluent and

2.)    Quality form required to be completed for each location the vaccine will be stored

 

The forms do not need to be completed ahead of the call as we will briefly discuss the requirements with you however as both are required for us to start the process of confirming delivery logistics, it would be great to have them returned by this coming Monday (or sooner if you already have the necessary information).  I will be sharing some additional information with you during the call – no need to prepare anything in advance as the rest of the items we hope will be relatively straight forward.  We are looking forward to meeting with you and the team tomorrow!

 

With our thanks in advance.


Regards,
Alvin 

 

From: Tamar Gabunia <tgabunia@moh.gov.ge>
Sent: Monday, March 1, 2021 8:08 AM
To: Rosie Grieves (Consultant <rgrieves@gavi.org>; Akande, Michelle <Michelle.Akande@pfizer.com>; Sousa, Patricia <Patricia.A.Sousa@pfizer.com>; Liu, Alvin <Alvin.Liu@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>; gkhalil@unicef.org; domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>; etikaradze@yahoo.de; sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; etikaradze@yahoo.de
Subject: [EXTERNAL] FW: Pfizer/BioNTech- Indemnification Agreement
Importance: High

 

Dear Pfizer Colleagues

Dear Rosie

 

As advised by the Letter issued on February 22nd, we are waiting for the time for the tripartite teleconsultation. However, meanwhile  I am sending the signed In&L agreement and the side letter for your review and approval. We will be making amendments as needed after the call.

I look forward to hearing from you on next steps.

 

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

 

Sincerely,

Tamar Gabunia, MD, MPH

First Deputy Minister

 

cid:image001.jpg@01D50033.645805C0

 

 

 

From: Tamar Gabunia [mailto:tgabunia@moh.gov.ge]
Sent: Friday, February 26, 2021 9:39 PM
To: Rosie Grieves (Consultant) <rgrieves@gavi.org>; Akande, Michelle <Michelle.Akande@pfizer.com>; Sousa, Patricia <Patricia.A.Sousa@pfizer.com>; Liu, Alvin HL <alvin.liu@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>; gkhalil@unicef.org; domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler (Consultant) <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>; etikaradze@yahoo.de; sgagua@gov.ge
Subject: Pfizer/BioNTech- Indemnification Agreement
Importance: High

 

Dear Pfizer Colleagues

Dear Rosie

 

The Government of Georgia has been advised by the Director-General of WHO - Dr Tedros Adhanom Ghebreyesus that one of the prerequisites for urgently accelerating deployment of Pfizer-BioNtech vaccine to Georgia was confirmation that the arbitration provision in the Indemnification Agreement and Side Letter is enforceable. With this e-mail I am sending the letter issued by the Ministry of Justice of Georgia confirming that the arbitration provision in the above mentioned agreement is enforceable in Georgia.  Please find the attached letter.

I look forward to our tripartite teleconsultation next week to finalize endorsement of the agreement and a side letter.

Many thanks for your cooperation.

 

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

 

Sincerely,

Tamar Gabunia, MD, MPH

First Deputy Minister

 

cid:image001.jpg@01D50033.645805C0

 

 

 

From: Rosie Grieves (Consultant) [mailto:rgrieves@gavi.org]
Sent: 22 February, 2021 21:32
To: Tamar Gabunia <tgabunia@moh.gov.ge>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>; gkhalil@unicef.org; domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler (Consultant) <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Liu, Alvin HL <alvin.liu@pfizer.com>; Akande, Michelle <Michelle.Akande@pfizer.com>; Sousa, Patricia <Patricia.A.Sousa@pfizer.com>
Subject: Update on Pfizer/BioNTech

 

Dear Tamar, 

 

I am writing to share an update on the initial limited volume of the COVID-19 vaccine requiring ultra-cold chain produced by Pfizer/BioNTech. After several conversations with Pfizer over the last three weeks, we can now provide more information for your planning purposes.  Thank you for your patience as we have worked through these issues.

 

Key next steps are outlined in the letter attached. I will be in touch to arrange a meeting for later this week between Pfizer, Government of Georgia and Covax to discuss further.

 

Best wishes

 

Rosie

 

Rosie Grieves

cid:image005.png@01D70C87.BD36EA50

Senior Manager Country Engagement 

Mobile: +44 7849 574189

Web: gavi.org

cid:image006.png@01D70C87.BD36EA50

 

cid:image007.png@01D70C87.BD36EA50

 

NOTICE: This email, including any attachments to it, may be confidential and does not create any binding contract on behalf of Gavi or its partners.

If this email was sent to you in error, please notify the send